Table 1

Baseline clinical characteristics of the study population

VariableAll patients (n = 40)
Values are mean (SD) or n (%).
*Medical treatment at inclusion.
†Patients on only one of the three classes of antianginal drugs.
‡Patients on only sublingual glyceryl trinitrate at inclusion.
ACE, angiotensin converting enzyme; CAD, coronary artery disease; CCS, Canadian Cardiovascular Society; F, female; GTN, glyceryl trinitrate; M, male; MI, myocardial infarction.
Age (years)56 (6)
Sex (M/F)36/4 (90%)
Cholesterol (mmol/l)6 (1)
Triglycerides (mmol/l)1.9 (1.3)
Hypertension (yes/no)15/25 (37%)
Parental CAD (yes/no)19/21 (48%)
Smoking (yes/no)23/17 (57%)
CCS anginal class
    116 (40%)
    219 (48%)
    35 (12%)
Diseased coronary arteries
    12 (6%)
    217 (42%)
    321 (52%)
Previous MI (yes/no)21/19 (53%)
Drugs*
    β Blockers21/40 (53%)
    Calcium channel blockers21/40 (53%)
    Long acting nitrates10/40 (25%)
    Lipid lowering6/40 (15%)
    Statins3/40 (8%)
    Fibrates3/40 (8%)
    Antiplatelets14/40 (35%)
    Diuretics6/40 (15%)
    ACE inhibitors5/40 (13%)
    Monotherapy†19/40 (48%)
    GTN only‡7/40 (18%)